TECHNOLOGY:  

Point-of-care Diagnostic for Malaria and Sickle Cell Disease

AFFILIATION:   Hemex Health, Portland, Oregon, United States

TECHNOLOGY SUMMARY

Track: Medical & Biotech
Area: Infectious Disease
Tech Readiness: TRL 5

Tech Brief: Portable diagnostic device that accurately detects all types of malaria in 1 minute and hemoglobin variants in 8 minutes. Uses one drop of blood and test can be easily taken by entry level healthcare worker.

FIGURES OF MERIT

Value Proposition: Hemex's malaria diagnostic is faster, more sensitive and very affordable. Rapid: 1 minute versus 20 minutes for RDTs and 30-60 for microscopy More sensitive: Accurate down to 10 p/uL versus 200 p/uL for RDTs and 50 p/uL for top microscopists Affordable: priced comparable to RDTs and much less than the cost of using trained microscopists. Approx $1/test It is breakthrough for screening because the sensitivity will detect asymptomatic malaria, will find P. vivax which typically is a lower levels and fast enough to check more people quickly. The test can be taken by lower level healthcare workers with minimal training. It can have significant impact on elimination efforts due to its high sensitivity and specificity, can improve testing in remote areas, and allow rapid screening at borders. It is a more practical alternative to microscopy than RDTs.

SHOWCASE SUMMARY

Org Type: Mid-stage Startup (A or B)
Website: http://www.hemexhealth.com